Podcast highlights prediction markets entering biotech and Biogen Alzheimer's drug controversy
The Readout LOUD episode released on July 16, 2026 features hosts Elaine Chen, Adam Feuerstein and Allison DeAngelis. The trio discuss trends shaping biotech, from new obesity treatments to evolving drug payment models.
The show announces that Kalshi, a platform known for prediction markets, is extending its services to biotech. Listeners will soon be able to place bets on the outcomes of clinical trials and FDA reviews, offering a novel way to gauge market sentiment on drug development.
The hosts also examine a controversy surrounding an experimental Alzheimer’s disease treatment being developed by Biogen. While details are limited, the discussion highlights concerns raised by the scientific community and the potential impact on the company’s pipeline.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “Predicting biotech clinical trials and a new Alzheimer’s drug controversy”
read at STAT ↗
comments(0)
5-min edit window · permanent after that